Patient and provider perspective on financial burden after an allogeneic hematopoietic cell transplantation

被引：0
|
作者：
Kim, Sunny Wonsun
Abel, Gregory Alan
McNulty, Julie
Weise, Mary
Coronado, Diana Salas
Hashml, Shahrukh
Roy, Vivek
Tliburt, Jon Charles
Albelda, Randy
Khera, Nandita
机构：
[1] Arizona State Univ, Phoenix, AZ USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Mayo Clin Arizona, Phoenix, AZ USA
[4] Univ Massachusetts, Boston, MA 02125 USA
[5] Mayo Clin, Rochester, MN USA
[6] Mayo Clin, Jacksonville, FL 32224 USA
[7] Mayo Clin Arizona, Div Hematol Oncol, Phoenix, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e17539
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17539
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Financial burden after allogeneic hematopoietic cell transplantation: a qualitative analysis from the patient’s perspective
    W Kim
    J McNulty
    Y-H Chang
    M Weise
    S Hashmi
    S Ailawadhi
    N Khera
    Bone Marrow Transplantation, 2015, 50 : 1259 - 1261
  • [2] Financial burden after allogeneic hematopoietic cell transplantation: a qualitative analysis from the patient's perspective
    Kim, W.
    McNulty, J.
    Chang, Y-H
    Weise, M.
    Hashmi, S.
    Ailawadhi, S.
    Khera, N.
    BONE MARROW TRANSPLANTATION, 2015, 50 (09) : 1259 - 1261
  • [3] Financial Burden in Recipients of Allogeneic Hematopoietic Cell Transplantation
    Khera, Nandita
    Chang, Yu-hui
    Hashmi, Shahrukh
    Slack, James
    Beebe, Timothy
    Roy, Vivek
    Noel, Pierre
    Fauble, Veena
    Sproat, Lisa
    Tilburt, Jon
    Leis, Jose F.
    Mikhael, Joseph
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (09) : 1375 - 1381
  • [4] Financial Burden In Recipients Of Allogeneic Hematopoietic Cell Transplantation
    Khera, Nandita
    Chang, Yu-hui
    Hashmi, Shahrukh K.
    Slack, James L.
    Fauble, Veena
    Beebe, Timothy
    Roy, Vivek
    Sproat, Lisa
    Leis, Jose F.
    Noel, Pierre
    Tilburt, Jon
    Mikhael, Joseph R.
    BLOOD, 2013, 122 (21)
  • [5] Estimating the Lifetime Medical Cost Burden of an Allogeneic Hematopoietic Cell Transplantation Patient
    Maziarz, Richard T.
    Devine, Steven
    Garrison, Louis P.
    Agodoa, Irene
    Badaracco, Jack
    Gitlin, Matthew
    Perales, Miguel-Angel
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (10): : 637.e1 - 637.e9
  • [6] Allogeneic hematopoietic cell transplantation: A historical perspective
    Storb, R
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2004, 31 (01) : 21 - 32
  • [7] Kidney Transplantation After Allogeneic Hematopoietic Cell Transplantation
    Ziliotis, Marie -Julia
    Vauchy, Charline
    Deconinck, Eric
    Berceanu, Ana
    Buchler, Mathias
    Caillard, Sophie
    Couzi, Lionel
    Dussol, Bertrand
    Frimat, Luc
    Hazzan, Marc
    Jaulin, Jean -Paul
    Malvezzi, Paolo
    Latour, Regis Peffault de
    Ducloux, Didier
    Courivaud, Cecile
    KIDNEY INTERNATIONAL REPORTS, 2024, 9 (04): : 1127 - 1131
  • [8] Symptom Burden and Recovery in the First Year After Allogeneic Hematopoietic Stem Cell Transplantation
    Eriksson, Linda Victoria
    Holmberg, Katarina
    Lundh Hagelin, Carina
    Wengstrom, Yvonne
    Bergkvist, Karin
    Winterling, Jeanette
    CANCER NURSING, 2023, 46 (01) : 77 - 85
  • [9] Financial Hardship and Patient-Reported Outcomes after Hematopoietic Cell Transplantation
    Abel, Gregory A.
    Albelda, Randy
    Khera, Nandita
    Hahn, Theresa
    Coronado, Diana Y. Salas
    Odejide, Oreofe O.
    Bona, Kira
    Tucker-Seeley, Reginald
    Soiffer, Robert
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (08) : 1504 - 1510
  • [10] THE CLINICAL AND FINANCIAL BURDEN OF PREEMPTIVE MANAGEMENT OF CMV DISEASE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
    Barrett, A.
    Jain, N.
    Ito, S.
    Lu, K.
    Muranski, P.
    Childs, R.
    Hourigan, C.
    Haggerty, J.
    Ramos, C.
    Cook, L.
    Battiwalla, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S331 - S331
12345